| Matthew Stephen Hambuchen, | |
|
3201 N Reynolds, Bryant, AR 72022 | |
| (501) 847-0803 | |
| Not Available |
| Full Name | Matthew Stephen Hambuchen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3201 N Reynolds, Bryant, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609471770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD11798 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Stephen Hambuchen, 2313 Richland Park Dr, Bryant, AR 72022-2686 Ph: () - | Matthew Stephen Hambuchen, 3201 N Reynolds, Bryant, AR 72022 Ph: (501) 847-0803 |
News Archive
A recent study finds that a new compound reverses many of the major symptoms associated with Fragile X syndrome (FXS), the most common form of inherited intellectual disability and a leading cause of autism. The paper, published by Cell Press in the April 12 issue of the journal Neuron, describes the exciting observation that the FXS correction can occur in adult mice, after the symptoms of the condition have already been established.
Many mental health therapists use treatments that have little evidence to support them. A new multi-institution study led by Penn Medicine has found that an organization's culture and climate are better predictors of the use of evidence-based practices than an individual therapist's characteristics in the treatment of children and adolescents with psychiatric disorders.
An anticancer agent in development promotes regeneration of damaged heart muscle 0- an unexpected research finding that may help prevent congestive heart failure in the future.
PharmaEngine, Inc. today announced that a New Drug Application (NDA) has been submitted to the Taiwan Food and Drug Administration (TFDA) for MM-398 (irinotecan liposome injection, also known as nal-IRI) in patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy.
› Verified 4 days ago
Me-kyoung Choi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3220 N Reynolds Rd, Bryant, AR 72022 Phone: 501-847-0803 | |
Sheree Mcconkey, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 304 Monticello W, Bryant, AR 72022 Phone: 501-847-6620 | |
Keri Stuff, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5500 Highway 5 N, Bryant, AR 72022 Phone: 501-847-7420 | |
Jeffrey Reagan Limbaugh Snow, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Highway 5 N, Bryant, AR 72022 Phone: 501-847-2880 | |
Jamie Bourland, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7377 Alcoa Rd, Bryant, AR 72022 Phone: 501-620-0334 | |
D'lisa Renee Haas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5500 Highway 5 N, Bryant, AR 72022 Phone: 501-847-7420 | |
Benjamin Ramsey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2203 N Reynolds Rd, Bryant, AR 72022 Phone: 501-481-8964 |